Similar articles for PMID: 21989426

Year	Number of Results
1998	1
2001	2
2002	2
2003	1
2005	4
2006	2
2007	4
2008	5
2009	3
2010	5
2011	4
2012	4
2013	1
2014	4
2015	3
2016	3
2017	5
2018	3
2019	4
2021	2
2022	2
2024	0

1

Chromatin binding by the androgen receptor in prostate cancer.

Itkonen H, Mills IG. Itkonen H, et al. Mol Cell Endocrinol. 2012 Sep 5;360(1-2):44-51. doi: 10.1016/j.mce.2011.09.037. Epub 2011 Oct 2. Mol Cell Endocrinol. 2012. PMID: 21989426 Review.

2

Regulation of FGF8 expression by the androgen receptor in human prostate cancer.

Gnanapragasam VJ, Robson CN, Neal DE, Leung HY. Gnanapragasam VJ, et al. Oncogene. 2002 Aug 1;21(33):5069-80. doi: 10.1038/sj.onc.1205663. Oncogene. 2002. PMID: 12140757

3

FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells.

Takayama K, Horie-Inoue K, Ikeda K, Urano T, Murakami K, Hayashizaki Y, Ouchi Y, Inoue S. Takayama K, et al. Biochem Biophys Res Commun. 2008 Sep 19;374(2):388-93. doi: 10.1016/j.bbrc.2008.07.056. Epub 2008 Jul 18. Biochem Biophys Res Commun. 2008. PMID: 18640093

4

Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells.

Takayama K, Tsutsumi S, Katayama S, Okayama T, Horie-Inoue K, Ikeda K, Urano T, Kawazu C, Hasegawa A, Ikeo K, Gojyobori T, Ouchi Y, Hayashizaki Y, Aburatani H, Inoue S. Takayama K, et al. Oncogene. 2011 Feb 3;30(5):619-30. doi: 10.1038/onc.2010.436. Epub 2010 Oct 4. Oncogene. 2011. PMID: 20890304

5

Cistromics of hormone-dependent cancer.

Lupien M, Brown M. Lupien M, et al. Endocr Relat Cancer. 2009 Jun;16(2):381-9. doi: 10.1677/ERC-09-0038. Epub 2009 Apr 15. Endocr Relat Cancer. 2009. PMID: 19369485 Review.

6

Androgen receptor amplification is reflected in the transcriptional responses of Vertebral-Cancer of the Prostate cells.

Makkonen H, Kauhanen M, Jääskeläinen T, Palvimo JJ. Makkonen H, et al. Mol Cell Endocrinol. 2011 Jan 1;331(1):57-65. doi: 10.1016/j.mce.2010.08.008. Epub 2010 Aug 20. Mol Cell Endocrinol. 2011. PMID: 20728506

7

Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.

Sun A, Tang J, Hong Y, Song J, Terranova PF, Thrasher JB, Svojanovsky S, Wang HG, Li B. Sun A, et al. Prostate. 2008 Mar 1;68(4):453-61. doi: 10.1002/pros.20723. Prostate. 2008. PMID: 18196538

8

Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.

Zaia A, Fraizer GC, Piantanelli L, Saunders GF. Zaia A, et al. Anticancer Res. 2001 Jan-Feb;21(1A):1-10. Anticancer Res. 2001. PMID: 11299720

9

Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3' untranslated region.

Thomas MA, Preece DM, Bentel JM. Thomas MA, et al. Biochem J. 2010 Jan 15;425(3):575-83. doi: 10.1042/BJ20091109. Biochem J. 2010. PMID: 19886863

10

Identification of ETS-like transcription factor 4 as a novel androgen receptor target in prostate cancer cells.

Makkonen H, Jääskeläinen T, Pitkänen-Arsiola T, Rytinki M, Waltering KK, Mättö M, Visakorpi T, Palvimo JJ. Makkonen H, et al. Oncogene. 2008 Aug 21;27(36):4865-76. doi: 10.1038/onc.2008.125. Epub 2008 May 12. Oncogene. 2008. PMID: 18469865

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

54 results

Results by year